Background and Objectives: Fungal peritonitis increases the risk of transfer to haemodialysis and mortality. Methods: We audited the effect of co-prescription of daily oral fluconazole with antibiotics in the Pan Thames centres on fungal peritonitis. Results: We found 49 (1.5%) fungal peritonitis cases in 3,322 episodes of peritonitis. Two centres co-prescribed prophylactic fluconazole with antibiotics, with a fungal peritonitis rate of 0.0032/patient year, compared to 0.0099 from centres not using prophylaxis. However, centres using fungal prophylaxis had lower peritonitis rates of 0.036, compared to 0.05 for the other centres. Correcting for background peritonitis rates, there was no significant difference in the incidence of fungal peritonitis. Conclusions: In centres with a low incidence of fungal peritonitis, additional co-prescription of fluconazole with antibiotics appeared to reduce the risk of fungal peritonitis. However, variation in practice between centres is the main determinant of the observed incidence of fungal peritonitis rather than the use of antifungal prophylaxis.

Keywords:
Peritoneal dialysis, Fungal peritonitis, Prophylaxis, Fluconazole
1.
Davenport A: Peritonitis remains the major clinical complication of peritoneal dialysis: the London, UK, peritonitis audit 2002–2003. Perit Dial Int 2009;29:297–302.
2.
Miles R, Hawley CM, McDonald SP, Brown FG, Rosman JB, Wiggins KJ, Bannister KM, Johnson DW: Predictors and outcomes of fungal peritonitis in peritoneal dialysis patients. Kidney Int 2009;76:622–628.
3.
Michel C, Courdavault L, al Khayat R, Viron B, Roux P, Mignon F: Fungal peritonitis in patients on peritoneal dialysis. Am J Nephrol 1994;14:113–120.
4.
Amici G, Grandesso S, Mottola A, Virga G, Calconi G, Bocci C: Fungal peritonitis in peritoneal dialysis: critical review of six cases. Avd Perit Dial 1994;10:169–173.
5.
Chenk IK, Fang GX, Chan TM, Chan PC, Chan MK: Fungal peritonitis complicating peritoneal dialysis: report of 27 cases and review of the treatment. Q J Med 1989;71:407–416.
6.
Robitaille P, Mérouani A, Clermónt MJ, Hébert E: Successful antifungal prophylaxis in chronic peritoneal dialysis: a pediatric experience. Perit Dial Int 1995;15:77–79.
7.
Lo WK, Chan CY, Cheng SW, Poon JF, Chan DT, Cheng IK: A prospective randomised control study of oral nystatin prophylaxis for Candida peritonitis complicating continuous ambulatory peritoneal dialysis. Am J Kidney Dis 1996;28:549–552.
8.
Chen CM, Ho MW, Yu WL, Wang JH: Fungal peritonitis in peritoneal dialysis patients: effect of fluconazole treatment and use of the twin-bag disconnect system. J Microbiol Immunol Infect 2004;37:115–120.
9.
Thodis E, Vas SI, Bargman JM, Singhal M, Chu M, Oreopoulos DG: Nystatin prophylaxis: its inability to prevent fungal peritonitis in patients on continuous ambulatory peritoneal dialysis. Perit Dial Int 1998;18:583–589.
10.
Williams PF, Moncrieff N, Marriott J: No benefit in using nystatin prophylaxis against fungal peritonitis in peritoneal dialysis patients. Perit Dial Int 2000;20:352–353.
11.
Piraino B, Bailie GR, Bernardini J, Boeschoten E, Gupta A, Holmes C, Kuijper EJ, Li PK, Lye WC, Mujais S, Paterson DL, Fontan MP, Ramos A, Schaefer F, Uttley L, ISPD Ad Hoc Advisory Committee: Peritoneal dialysis-related infections recommendations: 2005 update. Perit Dial Int 2005;25:107–131.
12.
Wang AY, Yu AW, Li PK, Lam PK, Leung CB, Lai KN, Lui SF: Factors predicting outcome of fungal peritonitis in peritoneal dialysis patients: analysis of a 9 year experience of fungal peritonitis in a single centre. Am J Kidney Dis 2000;36:1183–1192.
13.
Glorieux G, Lameire N, Van Biesen W, Dequidt C, Vanholder R: Specific characteristics of peritoneal leucocyte populations during sterile peritonitis associated with icodextrin CAPD fluids. Nephrol Dial Transplant 2003;18:1648–1653.
14.
Prasad N, Gupta A: Fungal peritonitis in peritoneal dialysis patients. Perit Dial Int 2005;25:207–222.
15.
Nagappan R, Collins JF, Lee WT: Fungal peritonitis in continuous ambulatory peritoneal dialysis – the Auckland experience. Am J Kidney Dis 1992;20:492–496.
16.
Lo WK, Chan TM, Lui SL, Li FK, Cheng IK: Fungal peritonitis – current status 1998. Perit Dial Int 1999;19(suppl 2):S286–S290.
17.
Restrepo C, Chacon J, Manjarres G: Fungal peritonitis in peritoneal dialysis patients: successful prophylaxis with fluconazole, as demonstrated by a prospective randomised controlled trial. Perit Dial Transplant 2101;30:619–625.
18.
Morey A, Lima C, Matas B, Munar MA: Profilaxis con fluconazol de las peritonitis fungicas en dialisis peritoneal. Nefrologia 2001;21:608.
19.
Plaza MM, Roman AV, Rodriquez MS, Pinero DF: Ten years without fungal peritonitis: a single centre’s experience. Perit Dial Int 2007;27:460–463.
20.
Wong PN, Lo KY, Tong GM, Chan SF, Lo MW, Mak SK, Wong AK: Prevention of fungal peritonitis with nystatin prophylaxis in patients receiving CAPD. Perit Dial Int 2007;27:531–536.
© 2011 S. Karger AG, Basel
2011
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.